Suppr超能文献

基于药房的 HIV 暴露前预防服务提供干预措施在华盛顿哥伦比亚特区(DC)的开发:一项研究方案。

Development of a pharmacy-based HIV PrEP service delivery intervention for Washington, District of Columbia (DC): A study protocol.

机构信息

Population Council, Washington, DC, United States of America.

Milken Institute School of Public Health, George Washington University, Washington, DC, United States of America.

出版信息

PLoS One. 2024 Oct 16;19(10):e0311694. doi: 10.1371/journal.pone.0311694. eCollection 2024.

Abstract

Pharmacy-based PrEP service delivery models can help address many of the barriers that inhibit the uptake of PrEP. In an increasing number of states, legislation has been passed, or is under consideration, to allow pharmacists to initiate PrEP without a prescription from a physician or other prescriber. However, there is not yet legislation in Washington, DC to allow pharmacy-based PrEP despite its potential to curb new cases of HIV, which disproportionately affect the Black community in the area. The DC Ends HIV Plan has a goal of less than 130 new cases of HIV per year by 2030, which would require that over 13,000 high-risk residents use PrEP. However, in 2021 only 6,724 Washingtonians were taking PrEP. This study seeks to address the absence of critical formative research into the factors that would influence the implementation of pharmacy-based PrEP in Washington DC using the Implementation Mapping (IM) framework. A needs assessment will be conducted through in-depth interviews (IDIs) with pharmacists (n = 6), PrEP providers (n = 6), current PrEP users (n = 6), DC Department of Health officials (n = 2), DC Board of Pharmacy officials (n = 4) and pharmacy-based PrEP experts (n = 4) to provide input on the operational aspects of pharmacy-based PrEP model as a strategy to increase PrEP uptake. Information gathered through this needs assessment will be used to develop standard operating procedures for the introduction of pilot pharmacy-based PrEP into community-based retail pharmacies.

摘要

基于药房的 PrEP 服务提供模式可以帮助解决许多阻碍 PrEP 采用的障碍。在越来越多的州,已经通过或正在考虑立法,允许药剂师在没有医生或其他处方者处方的情况下启动 PrEP。然而,华盛顿特区尚未允许基于药房的 PrEP,尽管它有可能遏制新的艾滋病毒感染病例,而该地区的黑人社区受到的影响不成比例。华盛顿特区终结艾滋病毒计划的目标是到 2030 年每年艾滋病毒新感染病例少于 130 例,这将需要超过 13000 名高风险居民使用 PrEP。然而,2021 年只有 6724 名华盛顿人在服用 PrEP。本研究旨在使用实施映射 (IM) 框架解决在华盛顿特区实施基于药房的 PrEP 缺乏关键形成性研究的问题。将通过与药剂师(n=6)、PrEP 提供者(n=6)、当前 PrEP 用户(n=6)、华盛顿特区卫生部门官员(n=2)、华盛顿特区药剂师委员会官员(n=4)和基于药房的 PrEP 专家(n=4)进行深入访谈 (IDI) 进行需求评估,就作为增加 PrEP 采用率的策略的基于药房的 PrEP 模式的运营方面提供意见。通过这项需求评估收集的信息将用于制定将试点基于药房的 PrEP 引入社区零售药房的标准操作程序。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd33/11482685/dd19122bd68f/pone.0311694.g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验